Nuo Therapeutics Company
%20.jpg)
Nuo Therapeutics is a biotechnology company that develops, sells, and licenses regenerative biological therapies to primarily address the areas of wound care, inflammation, and angiogenesis. The Company markets the AutoloGel System, a device for the production of platelet rich plasma gel derived from the patient's own blood. The AutoloGel System is cleared by the United States Food and Drug Administration for use on a variety of exuding wounds. Nuo Therapeutics is headquartered in Gaithersburg, Maryland.
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO
Headquarters:
Gaithersburg, Maryland, United States
Founded Date:
1987-01-01
Investor Type:
For Profit
Total Funding:
$112.8M
Technology:
Others
Employee Number:
11-50
Acquisitions Number:
1
Estimated Revenue:
Less than $1M
Investors Number:
3
Industry:
Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical, Therapeutics, Wellness